← Back to patent-cliff list
Olisutrigine bromide
Tier C — Watch / tradeOlisutrigine bromide
Asana Biosciences Llc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
-
Type
Targets：ENaC
Indications (approved)：Pruritus, Atopic dermatitis, Eczema
Regional status
US
Phase II
2023-05-03
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Olisutrigine bromide?
Approved indications include: Pruritus, Atopic dermatitis, Eczema.
When does the Olisutrigine bromide patent expire?
No public expiry year is available for Olisutrigine bromide yet; this page updates once verified.
How do I get a quote for Olisutrigine bromide intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-21